| (210) | Number of the EPO application | 19849948 |
| (220) | Filing date of the EPO application | 2019.08.16 |
| (80) | EPO patent specification publication (B) | EPB nr. 40/2025, 2025.10.01 |
| (110) | EPO patent number | 3836920 |
| (21) | Number of the application | e 2021 0578 |
| (71) | Name(s) of applicant(s), code of the country | Eidos Therapeutics, Inc., US; |
| (72) | Name(s) of inventor(s), code of the country | JERNELIUS Jesper, US;
MENNING Mark Michael, US; |
| (73) | Name(s) of owner(s), code of the country | Eidos Therapeutics, Inc., US; |
| (54) | Title of the invention | FORMULATIONS OF AG10 |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | A61K 31/415 (2006.01.01); A61K 9/20 (2006.01.01) |
| (52) | Cooperative Patent Classification | A61K 31/415 (EP); A61K 9/2054 (EP) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2021.07.31 |
| (30) | Priority | 201862765154 P, 2018.08.17, US |
| (86) | International application | PCT/US2019/046789, 2019.08.16 |
| (87) | International publication | WO 2020/037189, 2020.02.20 |